Published in Curr Top Microbiol Immunol on January 01, 1977
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A (1983) 14.73
A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J (1984) 10.28
Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A (1983) 6.81
DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J (1983) 5.42
Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol (1987) 5.00
Molecular cloning of viral DNA from human genital warts. J Virol (1981) 4.50
Characterization of primary human keratinocytes transformed by human papillomavirus type 18. J Virol (1988) 3.54
Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells. J Virol (1986) 3.03
Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol (1997) 2.58
Papillomavirus genomes in human cervical tumors: analysis of their transcriptional activity. Proc Natl Acad Sci U S A (1985) 2.48
Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci U S A (1987) 2.40
Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. BMJ (1989) 1.84
Characterization of a cell type-specific enhancer found in the human papilloma virus type 18 genome. EMBO J (1987) 1.67
Biochemical characterization of two types of human papillomaviruses associated with epidermodysplasia verruciformis. J Virol (1982) 1.58
Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus. J Clin Pathol (1990) 1.57
Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol (2003) 1.45
Isolation and characterization of a novel human papillomavirus type 6 DNA from an invasive vulvar carcinoma. J Virol (1986) 1.32
Human papilloma virus in neoplastic and non-neoplastic conditions of the external eye. Br J Ophthalmol (1997) 1.31
Condylomata acuminata and risk of cancer: an epidemiological study. BMJ (1991) 1.30
Identification of the human papillomavirus type 6b L1 open reading frame protein in condylomas and corresponding antibodies in human sera. J Virol (1987) 1.26
Human papillomavirus in pterygium. Br J Ophthalmol (2001) 1.22
Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology. Br J Cancer (2005) 1.18
Human papillomaviruses: genetic basis of carcinogenicity. Public Health Genomics (2009) 1.18
Localization of viral DNA-replication in sections of human warts by nucleic acid hybridization with complementary RNA of human papilloma virus Type 1. Arch Dermatol Res (1979) 1.16
HPV type 16 in conjunctival and junctional papilloma, dysplasia, and squamous cell carcinoma. J Clin Pathol (1995) 1.15
Detection of human papillomavirus DNA in biopsies of human oral tissue. Br J Cancer (1987) 1.15
A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Proc Natl Acad Sci U S A (1989) 1.13
European elk papillomavirus: characterization of the genome, induction of tumors in animals, and transformation in vitro. J Virol (1983) 1.11
Isolation of a novel human papillomavirus (type 51) from a cervical condyloma. J Virol (1988) 1.09
Human papillomavirus infection and anal carcinoma. Retrospective analysis by in situ hybridization and the polymerase chain reaction. Am J Pathol (1992) 1.08
Late promoter of human papillomavirus type 8 and its regulation. J Virol (1992) 1.06
Sexual behaviour of women with human papillomavirus (HPV) lesions of the uterine cervix. Br J Vener Dis (1984) 1.05
Expression of the p16 and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection. J Gynecol Oncol (2008) 1.02
Role of papillomaviruses. J Clin Pathol (1990) 1.01
Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010. Oral Oncol (2011) 1.01
Prevalence of high-risk human papillomavirus types in Mexican women with cervical intraepithelial neoplasia and invasive carcinoma. Infect Agent Cancer (2008) 1.00
Oxidative stress and HPV carcinogenesis. Viruses (2013) 1.00
A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers. J Biol Chem (2010) 1.00
Selective suppression of human papillomavirus transcription in non-tumorigenic cells by 5-azacytidine. EMBO J (1988) 0.99
Altered expression of filaggrin in human papillomavirus (HPV) lesions of the uterine cervix. Arch Gynecol Obstet (1988) 0.95
Is human papillomavirus associated with prostate cancer survival? Dis Markers (2013) 0.95
Viruses and human cancers: a long road of discovery of molecular paradigms. Clin Microbiol Rev (2014) 0.93
Characterization and analysis of human papillomaviruses of skin warts. Arch Dermatol Res (1993) 0.93
The biology and significance of human papillomavirus infections in the genital tract. Yale J Biol Med (1988) 0.93
Shope papilloma cell and leukocyte proliferation in regressing and progressing lesions. Am J Pathol (1993) 0.92
Screening for cervical intraepithelial neoplasia and cancer in the Sheffield STD clinic. Br J Vener Dis (1984) 0.92
Current status of human papillomavirus vaccines. Clin Exp Vaccine Res (2014) 0.91
Occurrence of HPV genomes in penile smears of healthy men. Arch Dermatol Res (1987) 0.91
Verrucous carcinoma of the anus containing human papillomavirus type 16 DNA detected by in situ hybridisation: a case report. Genitourin Med (1990) 0.90
Impaired pre-mRNA processing and altered architecture of 3' untranslated regions contribute to the development of human disorders. Int J Mol Sci (2013) 0.89
Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions. EMBO J (1991) 0.89
Detection of herpes simplex virus DNA in a cutaneous squamous cell carcinoma by in situ hybridization. Arch Dermatol Res (1989) 0.87
Association of human beta-herpesviruses with the development of cervical cancer: bystanders or cofactors. J Clin Pathol (2001) 0.86
Condylomata of the uterine cervix and koilocytosis of cervical intraepithelial neoplasia. J Clin Pathol (1981) 0.86
Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know. Eur Arch Otorhinolaryngol (2012) 0.85
In situ hybridization analysis of HPV DNA in cervical precancer and cervical cancers from China. Arch Gynecol Obstet (1990) 0.85
HPV-vaccination against cervical carcinoma: will it really work? Med Microbiol Immunol (2007) 0.84
Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review. World J Clin Cases (2014) 0.83
Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology. PLoS One (2015) 0.82
The role for surgical management of HPV-related oropharyngeal carcinoma. Head Neck Pathol (2012) 0.82
Biologic properties and nucleotide sequence analysis of human papillomavirus type 51. J Virol (1991) 0.82
Rat primary embryo fibroblast cells suppress transformation by the E6 and E7 genes of human papillomavirus type 16 in somatic hybrid cells. J Virol (1991) 0.82
A Decade of Global mRNA and miRNA Profiling of HPV-Positive Cell Lines and Clinical Specimens. Open Virol J (2012) 0.81
Clinical significance of human papillomavirus genotyping. J Gynecol Oncol (2016) 0.80
Long-Term Follow-up of HPV Infection Using Urine and Cervical Quantitative HPV DNA Testing. Int J Mol Sci (2016) 0.79
Immunoperoxidase demonstration of human papilloma virus (HPV) in dysplastic lesions of the uterine cervix. Arch Gynecol (1982) 0.79
Prediction of high-grade squamous intraepithelial lesions using the modified Reid index. Int J Clin Oncol (2010) 0.79
Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and promoter methylation in cervical oncogenic lesions and cancer. J Cell Mol Med (2013) 0.78
The use of urine in the follow-up of HPV vaccine trials. Hum Vaccin Immunother (2015) 0.78
In situ DNA hybridization analysis of human papillomavirus (HPV) sequences in benign oral mucosal lesions. Arch Dermatol Res (1987) 0.76
PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma. Oncotarget (2016) 0.76
Human papillomavirus vaccination: where to now? Sex Transm Infect (2011) 0.76
Long-term complications of infection of the female genital tract by intracellular sexually-transmitted microorganisms: a review. J R Soc Med (1983) 0.75
Risk of cervical intraepithelial neoplasia in women with glomerulonephritis. BMJ (1991) 0.75
[Histologic and electron microscopical investigations in a patient with benign verrucosis generalisata (author's transl)]. Arch Dermatol Res (1981) 0.75
Anogenital warts: epidemiology, treatment and association with cervical atypia. Ulster Med J (1987) 0.75
Coexistent chlamydial infections related to natural history of human papillomavirus lesions in uterine cervix. Genitourin Med (1986) 0.75
Carcinoma of the cervix: an infectious disease. Can Fam Physician (1989) 0.75
Viruses and squamous neoplasia of the lower female genital tract: an update. Bull N Y Acad Med (1982) 0.75
A molecular understanding of d-homoestrone-induced G2/M cell cycle arrest in HeLa human cervical carcinoma cells. J Cell Mol Med (2015) 0.75
Genetic polymorphisms of FAS and EVER genes in a Greek population and their susceptibility to cervical cancer: a case control study. BMC Cancer (2016) 0.75
Efficacy trial of topically administered interferon gamma-1 beta gel in comparison to laser treatment in cervical intraepithelial neoplasia. Arch Gynecol Obstet (1995) 0.75
[Virus infections of the vulva]. Arch Gynecol Obstet (1987) 0.75
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A (1983) 14.73
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature (1985) 11.11
A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J (1984) 10.28
Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature (1978) 9.25
EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature (1970) 8.08
Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A (1983) 6.81
Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol (1982) 5.49
DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J (1983) 5.42
Molecular cloning of viral DNA from human genital warts. J Virol (1981) 4.50
Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events? Lancet (1982) 4.31
Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNA. Int J Cancer (1982) 4.30
The nucleotide sequence and genome organization of human papilloma virus type 11. Virology (1986) 4.04
Partial characterization of viral DNA from human genital warts (Condylomata acuminata). Int J Cancer (1980) 4.03
Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med Microbiol Immunol (1987) 3.70
EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol (1973) 2.71
Condylomata acuminata and human genital cancer. Cancer Res (1976) 2.67
Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H. J Virol (1985) 2.56
Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc Natl Acad Sci U S A (1979) 2.55
Complete DNA sequence of lymphotropic papovavirus: prototype of a new species of the polyomavirus genus. Virology (1985) 2.53
Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology (1984) 2.49
Partial purification of the Epstein-Barr virus and some properties of its DNA. Virology (1970) 2.39
DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. Cancer Res (1988) 2.39
Human papillomavirus type-16-related DNA in genital Bowen's disease and in Bowenoid papulosis. Int J Cancer (1983) 2.30
Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst (1996) 2.28
Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helpervirus dependent parvovirus. Virology (1986) 2.26
Lymphotropic papovaviruses isolated from African green monkey and human cells. Med Microbiol Immunol (1979) 2.23
Structure of defective DNA molecules in Epstein-Barr virus preparations from P3HR-1 cells. J Virol (1984) 2.23
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology (1984) 2.13
Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet (1987) 2.13
Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography, and electron microscopy. J Virol (1967) 2.07
Oncogenic Herpes viruses. Biochim Biophys Acta (1975) 2.01
The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification. J Virol (1990) 2.00
Characterization of a human papillomavirus from epidermodysplasia verruciformis lesions of a patient from Upper-volta. Int J Cancer (1981) 1.99
Attempts to detect virus-secific DNA in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart virus. Int J Cancer (1974) 1.98
Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J Virol (1999) 1.94
NC37-R1 Epstein-Barr virus (EBV): a possible recombinant between intracellular NC37 viral DNA and superinfecting P3HR-1 EBV. Intervirology (1980) 1.92
Analysis of early and late Epstein-Barr virus associated polypeptides by immunoprecipitation. Virology (1979) 1.85
Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet (1986) 1.82
Human papilloma virus DNA: physical mapping and genetic heterogeneity. Proc Natl Acad Sci U S A (1976) 1.76
Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1. EMBO J (1992) 1.74
Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J Virol (1998) 1.72
Papillomaviruses in human cancer. Cancer (1987) 1.71
B-lymphotropic papovavirus and possibility of infections in humans. J Med Virol (1981) 1.68
Genomic localization, sequence analysis, and transcription of the putative human cytomegalovirus DNA polymerase gene. J Virol (1987) 1.67
Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology (1992) 1.64
Canine oral papillomavirus genomic sequence: a unique 1.5-kb intervening sequence between the E2 and L2 open reading frames. Virology (1994) 1.63
Genital papillomavirus infections. Prog Med Virol (1985) 1.58
Viruses in the etiology of human genital cancer. Prog Med Virol (1984) 1.54
A subset of herpes simplex virus replication genes induces DNA amplification within the host cell genome. J Virol (1989) 1.52
Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res (1994) 1.51
Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV. Int J Cancer (1978) 1.49
Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol (1985) 1.47
Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180. J Virol (1991) 1.42
Propagation of B-lymphotropic papovavirus (LPV) in human B-lymphoma cells and characterization of its DNA. Virology (1981) 1.37
Epstein-Barr virus-induced proteins. II. Analysis of surface polypeptides from EBV-producing and -superinfected cells by immunoprecipitation. Virology (1980) 1.34
Epstein-Barr virus-induced transformation of human leukocytes after cell fractionation. Int J Cancer (1975) 1.33
Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 anti-sense RNA. Int J Cancer (1992) 1.33
A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol (1992) 1.32
Presence of human papillomavirus in genital tumors. J Invest Dermatol (1984) 1.29
Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. J Virol (1991) 1.27
Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Res (1983) 1.25
Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells. Med Microbiol Immunol (1983) 1.25
Inhibition of initiator-induced SV40 gene amplification in SV40-transformed Chinese hamster cells by infection with a defective parvovirus. Int J Cancer (1983) 1.23
Multiplicity-dependent biological and biochemical properties of Epstein-Barr virus (EBV) rescued from non-producer lines after superinfection with P3HR-1 EBV. Int J Cancer (1980) 1.22
Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression. Oncogene (2001) 1.18
Analysis of benign and malignant urogenital tumors for human papillomavirus infection by labelling cellular DNA. Med Microbiol Immunol (1986) 1.17
Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc Natl Acad Sci U S A (1991) 1.17
Localization of viral DNA-replication in sections of human warts by nucleic acid hybridization with complementary RNA of human papilloma virus Type 1. Arch Dermatol Res (1979) 1.16
Papillomavirus DNA in human tongue carcinomas. Int J Cancer (1985) 1.16
Epstein-Barr virus-induced proteins. III. Analysis of polypeptides from P3HR-1-EBV-superinfected NC37 cells by immunoprecipitation. Virology (1980) 1.15
EBV DNA in nonlymphoid cells of nasopharyngeal carcinomas and in a malignant lymphoma obtained after inoculation of EBV into cottontop marmosets. Cold Spring Harb Symp Quant Biol (1975) 1.14
Unusual HPV types in oral warts in association with HIV infection. J Oral Pathol (1988) 1.13
BK virus: I. Seroepidemiologic studies and serologic response to viral infection. Med Microbiol Immunol (1978) 1.12
Effect of herpes simplex virus on cultured Burkitt tumor cells and its failure to influence the Epstein-Barr virus carrier state. Cancer Res (1969) 1.11
Tumour promoter TPA enhances transformation of human leukocytes by Epstein-Barr virus. Nature (1979) 1.11
Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins. J Virol (1997) 1.10
Interactions of adenovirus type 12 with host cell chromosomes. Prog Exp Tumor Res (1973) 1.10
Chromosomal changes of similar nature in seven established cell lines derived from the peripheral blood of patients with leukemia. J Natl Cancer Inst (1967) 1.10
Papillomavirus infections and human genital cancer. Gynecol Oncol (1981) 1.10
Attempts to demonstrate virus-specific sequences in human tumors. IV. EB viral DNA in European Burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis. Int J Cancer (1976) 1.09
The effect of DNA methylation on gene regulation of human papillomaviruses. J Gen Virol (1993) 1.09
Retinoic acid inhibition of Epstein-Barr virus induction. Nature (1979) 1.09
Adeno-associated viruses inhibit SV40 DNA amplification and replication of herpes simplex virus in SV40-transformed hamster cells. Virology (1988) 1.09
The role of viruses in human tumors. Adv Cancer Res (1980) 1.09
Epstein-Barr virus in human tumor cells. Int Rev Exp Pathol (1972) 1.08
Presence of human papillomavirus type-16 and type-18 DNA sequences and their expression in cervical cancers and cell lines from Japanese patients. Int J Cancer (1986) 1.07
Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription. J Virol (1997) 1.06
Molecular cloning of two new HPV types (HPV 37 and HPV 38) from a keratoacanthoma and a malignant melanoma. Int J Cancer (1986) 1.04
Selective killing of carcinogen-treated SV40-transformed Chinese hamster cells by a defective parvovirus. Virology (1984) 1.03
Characterization of a new human papillomavirus (HPV 41) from disseminated warts and detection of its DNA in some skin carcinomas. Int J Cancer (1988) 1.02
Mutants of adenovirus type 12 after adaptation to growth in tumor cell lines. II. Reproducible acquisition of additional sequences after adaptation to a human cervical cancer line. Int J Cancer (1981) 1.02
Heterogeneity of Epstein-Barr virus. II. Induction of early antigens (EA) by complementation. Virology (1977) 1.01
Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells. J Virol (1990) 1.01
Attempts to detect virus-specific DNA in human tumors. II. Nucleic acid hybridizations with complementary RNA of human herpes group viruses. Int J Cancer (1974) 1.00
Deletions and insertions in adenovirus type 12 DNA after viral replication in Vero cells. Virology (1978) 1.00